Chris Bateman: The grace of adversity – my cancer journey
Since his esophageal cancer diagnosis last November, Chris Bateman had no option but to blindly step forward on a journey towards an unknown destination.
chemotherapy
When the political gets really personal…
They say the political is always personal. Chris Bateman shares his knowledge of SA’s healthcare landscape and the Covid-19 coordinated response from his perspective.
đŸ”’ Inside with Chris Bateman: When Covid-19 and chemotherapy potentially collide
The deadly threat of Covid-19 multiples when one’s immune system is compromised, such as the three million HIV infected individuals not on ARV’s.
Half an hour’s inspiration from cancer surviving, crippled athlete from Singapore
Alec Hogg says William Tan is an incredible example of the odds we humans are capable of overcoming.
Rob Opie on cancer – cracking the code and conquering dread disease
Listen to Rob Opie, human brand specialist, author and man on a mission – talking about cancer and how to help people conquer it
Cracking the cancer code: just like Everest, cancer can be conquered
They don’t always make the headlines, and among the great champions are not just those who have conquered Everest or won Olympic gold, but also the many who have beaten cancer. It takes guts, perseverance and determination to face a life-threatening disease head on. Most of all, it takes a new ‘collaborative’ approach to conquering disease … Read more
Germany pushes faster route for new brain cancer drug
German health regulators, the toughest in Europe, have granted Northwest Biotherapeutics special permission to sell its experimental brain cancer drug, DCVax-L in the country, even though the small USÂ biotechnology company has not completed late-stage trial of the immunotherapy. The special “hospital exemption” would allow Northwest to sell DCVax-L for five years, and seek renewed … Read more
The flourishing members of business’s “second chance at life” club
Some months back, Business Day’s editor Peter Bruce asked whether I’d like to contribute to his fine newspaper. Back then it wasn’t possible because of my restraint of trade. But that ended in July, so my first column for Business Day appeared this week. Called Undictated it appears every Monday – one more reason to start your … Read more
The journo and the whistleblower: A decade later, revealing what the Rand Commission should have actually concluded and told SA
I met Barry Sergeant exactly three decades back. A young LLB graduate, he came for a job interview with my boss, the late David Carte, at the Sunday Times Business Times. Over the years I’ve sat in on hundreds of such interviews. That one I remember. Because when we asked Barry why journalism rather than … Read more